• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制造差异影响人骨髓基质细胞的特征和功能:来自多个中心的生产方法和产品的比较。

Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers.

机构信息

Cell Processing Section, Department of Transfusion Medicine, Clinical Center; National Institutes of Health, Bethesda, Maryland, USA.

Skeletal Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Sci Rep. 2017 Apr 27;7:46731. doi: 10.1038/srep46731.

DOI:10.1038/srep46731
PMID:28447618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5406832/
Abstract

Human bone marrow stromal cells (BMSCs, also known as bone marrow-derived mesenchymal stem cells) are manufactured using many different methods, but little is known about the spectrum of manufacturing methods used and their effects on BMSC characteristics and function. Seven centers using, and one developing, Good Manufacturing Practices (GMP) processes were surveyed as to their production methods. Among the seven centers, all used marrow aspirates as the starting material, but no two centers used the same manufacturing methods. Two to four BMSC lots from each center were compared using global gene expression. Among the twenty-four BMSC lots from the eight centers intra-center transcriptome variability was low and similar among centers. Principal component analysis and unsupervised hierarchical clustering analysis separated all the lots from five centers into five distinct clusters. BMSCs from six of the eight centers were tested for their ability to form bone and support hematopoiesis by in vivo transplantation (defining features of BMSCs). Those from all six centers tested formed bone, but the quantity formed was highly variable and BMSCs from only three centers supported hematopoiesis. These results show that differences in manufacturing resulted in variable BMSC characteristics including their ability to form bone and support hematopoiesis.

摘要

人骨髓基质细胞(BMSCs,也称为骨髓来源的间充质干细胞)可以通过许多不同的方法制造,但对于所使用的制造方法的范围及其对 BMSC 特性和功能的影响知之甚少。对七个使用(和一个正在开发)良好生产规范(GMP)工艺的中心进行了调查,以了解其生产方法。在这七个中心中,均使用骨髓抽吸物作为起始材料,但没有两个中心使用相同的制造方法。对每个中心的 2 到 4 个 BMSC 批次进行了比较,使用了全基因组表达谱分析。在八个中心的 24 个 BMSC 批次中,中心内转录组的变异性较低,且各中心之间相似。主成分分析和无监督层次聚类分析将五个中心的所有批次分为五个不同的簇。对八个中心中的六个中心的 BMSC 进行体内移植的成骨和成血能力测试(BMSC 的定义特征)。六个中心的 BMSC 都能形成骨,但形成的量差异很大,只有三个中心的 BMSC 支持成血。这些结果表明,制造工艺的差异导致 BMSC 特性发生变化,包括其成骨和成血能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/0c9ff94c925e/srep46731-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/a81468998d7b/srep46731-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/4942170c2878/srep46731-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/81a3927aefb1/srep46731-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/73ce06c6f211/srep46731-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/7c4cc18f9570/srep46731-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/4dacca5f1eb4/srep46731-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/0c9ff94c925e/srep46731-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/a81468998d7b/srep46731-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/4942170c2878/srep46731-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/81a3927aefb1/srep46731-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/73ce06c6f211/srep46731-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/7c4cc18f9570/srep46731-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/4dacca5f1eb4/srep46731-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c41/5406832/0c9ff94c925e/srep46731-f7.jpg

相似文献

1
Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers.制造差异影响人骨髓基质细胞的特征和功能:来自多个中心的生产方法和产品的比较。
Sci Rep. 2017 Apr 27;7:46731. doi: 10.1038/srep46731.
2
Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence.人类骨髓间充质干细胞(BMSC)复制性衰老的个体内变异性:与BMSC衰老相关的分子变化。
Stem Cell Res. 2013 Nov;11(3):1060-73. doi: 10.1016/j.scr.2013.07.005. Epub 2013 Jul 27.
3
Application of autologous cryopreserved bone marrow mesenchymal stem cells for periodontal regeneration in dogs.自体冷冻保存的骨髓间充质干细胞在犬牙周再生中的应用。
Cells Tissues Organs. 2009;190(2):94-101. doi: 10.1159/000166547. Epub 2008 Oct 28.
4
Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density.移植的人骨髓基质细胞形成造血区域和骨骼需要临界细胞密度。
Exp Hematol. 2007 Jun;35(6):995-1004. doi: 10.1016/j.exphem.2007.01.051.
5
Comparison of human bone marrow stromal cells cultured in human platelet growth factors and fetal bovine serum.人血小板生长因子与人胎牛血清培养的骨髓基质细胞比较。
J Transl Med. 2018 Mar 14;16(1):65. doi: 10.1186/s12967-018-1400-3.
6
Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue.人骨髓和脂肪组织间充质干细胞的鉴定与表达分析
Cell Physiol Biochem. 2004;14(4-6):311-24. doi: 10.1159/000080341.
7
Glial Cell Line-Derived Neurotrophic Factor-Transfected Placenta-Derived Versus Bone Marrow-Derived Mesenchymal Cells for Treating Spinal Cord Injury.胶质细胞源性神经营养因子转染的胎盘来源与骨髓来源间充质细胞治疗脊髓损伤的比较
Med Sci Monit. 2017 Apr 14;23:1800-1811. doi: 10.12659/msm.902754.
8
Ectopic osteogenesis by ex vivo gene therapy using beta tricalcium phosphate as a carrier.以β-磷酸三钙为载体的离体基因治疗诱导异位骨生成。
Connect Tissue Res. 2008;49(5):343-50. doi: 10.1080/03008200802325029.
9
Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.组织来源决定间充质干细胞的分化潜能:骨髓和脂肪组织来源的人骨髓间充质干细胞的比较研究。
Stem Cell Res Ther. 2017 Dec 6;8(1):275. doi: 10.1186/s13287-017-0716-x.
10
Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes.多参数分析人骨髓基质细胞鉴定出具有不同免疫调节和分化能力的亚型。
Stem Cell Reports. 2015 Jun 9;4(6):1004-15. doi: 10.1016/j.stemcr.2015.05.005.

引用本文的文献

1
Secretome and extracellular vesicle signatures in bone marrow-derived mesenchymal stromal cells after expansion in standard and next-generation media.在标准培养基和新一代培养基中扩增后骨髓间充质基质细胞的分泌组和细胞外囊泡特征
Extracell Vesicles Circ Nucl Acids. 2025 Apr 29;6(2):195-215. doi: 10.20517/evcna.2024.99. eCollection 2025.
2
RNA sequencing identifies and as predictive genes of aging CD264 human mesenchymal stem cells at an early passage.RNA测序鉴定出CD264人骨髓间充质干细胞早期传代时的衰老预测基因。 (原句中“identifies and as predictive genes”表述似乎不完整,推测原文可能是“identifies [genes] and [genes] as predictive genes” ,翻译时补充完整了成分。)
Cytotechnology. 2025 Apr;77(2):63. doi: 10.1007/s10616-025-00724-8. Epub 2025 Feb 19.
3

本文引用的文献

1
No Identical "Mesenchymal Stem Cells" at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels.不同时间和部位不存在相同的“间充质干细胞”:源自不同来源和具有不同分化潜能的人类定向祖细胞作为血管外膜细胞被整合入微血管中。
Stem Cell Reports. 2016 Jun 14;6(6):897-913. doi: 10.1016/j.stemcr.2016.05.011.
2
A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.一种用于测量间充质基质细胞介导的T细胞抑制作用的可重复性免疫效力测定法。
Cytotherapy. 2015 Feb;17(2):140-51. doi: 10.1016/j.jcyt.2014.10.002. Epub 2014 Nov 21.
3
Minor salivary gland stem cells: a comparative study of the biological properties under clinical-grade culture conditions.小唾液腺干细胞:临床级培养条件下生物学特性的比较研究。
Cell Tissue Res. 2023 Aug;393(2):321-342. doi: 10.1007/s00441-023-03789-z. Epub 2023 May 30.
4
Enhanced chondrogenic differentiation of iPS cell-derived mesenchymal stem/stromal cells via neural crest cell induction for hyaline cartilage repair.通过诱导神经嵴细胞增强诱导多能干细胞来源的间充质干/基质细胞的软骨形成分化用于透明软骨修复。
Front Cell Dev Biol. 2023 May 10;11:1140717. doi: 10.3389/fcell.2023.1140717. eCollection 2023.
5
Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach.在分散的多中心生产方法中,协调的培养方案可最大程度减少但不能消除间充质基质细胞供体和组织的变异性。
Stem Cell Res Ther. 2023 May 4;14(1):120. doi: 10.1186/s13287-023-03352-1.
6
Pretreated Mesenchymal Stem Cells and Their Secretome: Enhanced Immunotherapeutic Strategies.预处理间充质干细胞及其分泌组:增强的免疫治疗策略。
Int J Mol Sci. 2023 Jan 9;24(2):1277. doi: 10.3390/ijms24021277.
7
Cellular expansion of MSCs: Shifting the regenerative potential.MSC 的细胞扩增:改变再生潜能。
Aging Cell. 2023 Jan;22(1):e13759. doi: 10.1111/acel.13759. Epub 2022 Dec 19.
8
Putative critical quality attribute matrix identifies mesenchymal stromal cells with potent immunomodulatory and angiogenic "fitness" ranges in response to culture process parameters.推测关键质量属性矩阵确定了间充质基质细胞,这些细胞在应对培养过程参数时有较强的免疫调节和血管生成“适应度”范围。
Front Immunol. 2022 Nov 30;13:972095. doi: 10.3389/fimmu.2022.972095. eCollection 2022.
9
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.优化间充质基质细胞(MSC)制造工艺以获得更好的治疗效果。
Front Immunol. 2022 Jun 9;13:918565. doi: 10.3389/fimmu.2022.918565. eCollection 2022.
10
Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells.用于扩增人 GMP 级间充质基质细胞的血清和无动物源培养基的质量评估。
PeerJ. 2022 May 30;10:e13391. doi: 10.7717/peerj.13391. eCollection 2022.
Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.
间充质干细胞或基质细胞:临床应用和制造实践综述。
Transfusion. 2014 May;54(5):1418-37. doi: 10.1111/trf.12421. Epub 2013 Oct 16.
4
Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol.间充质基质细胞在急性肺损伤临床前模型中的疗效与安全性:一项系统评价方案
Syst Rev. 2014 May 23;3:48. doi: 10.1186/2046-4053-3-48.
5
Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System.使用量子细胞扩增系统高效制造治疗性间充质基质细胞。
Cytotherapy. 2014 Aug;16(8):1048-58. doi: 10.1016/j.jcyt.2014.01.417. Epub 2014 Apr 13.
6
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.自体间充质干细胞应用于接受冠状动脉搭桥术的患者时,可在局部功能、组织灌注和纤维化负担方面产生一致的改善:心脏手术患者间充质干细胞治疗的前瞻性随机研究(PROMETHEUS)试验。
Circ Res. 2014 Apr 11;114(8):1302-10. doi: 10.1161/CIRCRESAHA.114.303180. Epub 2014 Feb 24.
7
Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.临床级异体人骨髓间充质干细胞恢复移植排斥的人肺中的肺泡液体清除功能。
Am J Physiol Lung Cell Mol Physiol. 2014 May 1;306(9):L809-15. doi: 10.1152/ajplung.00358.2013. Epub 2014 Feb 14.
8
MSC-based product characterization for clinical trials: an FDA perspective.基于 MSC 的临床试验产品特征分析:FDA 的观点。
Cell Stem Cell. 2014 Feb 6;14(2):141-5. doi: 10.1016/j.stem.2014.01.013.
9
Bone marrow stromal cell assays: in vitro and in vivo.骨髓基质细胞检测:体内和体外实验
Methods Mol Biol. 2014;1130:279-293. doi: 10.1007/978-1-62703-989-5_21.
10
Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.骨髓间充质基质细胞治疗异基因干细胞移植受者的组织损伤:生物标志物与临床反应的相关性
Stem Cells. 2014 May;32(5):1278-88. doi: 10.1002/stem.1638.